May 13, 2026 08:30AM
Apr 22, 2026 08:30AM
Apr 7, 2026 08:30AM
Apr 29, 2024 07:04AM
Apr 29, 2024 07:00AM
Apr 17, 2023 07:00AM
Mar 20, 2023 08:00AM Oncotelic Announces Pet2DAO Website is Live
Mar 13, 2023 08:00AM
Feb 6, 2023 08:00AM
Jan 25, 2023 08:00AM
Jan 17, 2023 08:00AM
Dec 28, 2022 08:02AM
Dec 28, 2022 08:00AM
Dec 19, 2022 08:00AM Oncotelic Presents Clinical Data of Confirming TGF-β2 as the appropriate target for gliomas at JCA-AACR Meeting 2022
Nov 30, 2022 08:00AM
Nov 21, 2022 09:00AM
Nov 16, 2022 08:00AM
Nov 8, 2022 07:33AM
Sep 28, 2022 08:55AM
Sep 14, 2022 08:15AM
Aug 22, 2022 09:00AM ONCOTELIC REPORTS Q2 2022 COMPARED TO Q2 2021 FINANCIAL RESULTS
Aug 17, 2022 08:00AM
Jul 12, 2022 07:00AM
Jun 15, 2022 07:00AM
May 25, 2022 07:00AM
May 23, 2022 11:14AM
May 18, 2022 08:00AM
May 11, 2022 07:00AM ONCOTELIC ANNOUNCES US PATENT GRANT FOR CA4P AND OXI4503 COMBINATION WITH CHECKPOINT INHIBITORS
May 4, 2022 07:03AM
May 4, 2022 07:00AM
May 3, 2022 07:00AM
Apr 18, 2022 07:00AM
Apr 7, 2022 10:00AM
Apr 4, 2022 07:00AM
Mar 10, 2022 08:05AM Oncotelic to Present New Studies on its TGF-β Program at the American Association for Cancer Research (AACR) Annual Meeting 2022
Mar 3, 2022 08:01AM
Feb 24, 2022 08:47AM
Feb 24, 2022 08:01AM
Jan 19, 2022 09:05AM
Jan 5, 2022 08:01AM
Dec 1, 2021 09:01AM
Nov 23, 2021 07:30AM ONCOTELIC PROVIDES 3RD QUARTER 2021 COMPARED TO 3RD QUARTER 2020 FINANCIAL RESULTS AND CORPORATE UPDATE
Nov 16, 2021 08:15AM
Oct 4, 2021 07:00AM
Sep 1, 2021 12:00PM
Apr 19, 2021 12:00PM

322,243 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All